The role of the C-terminal domain in the inhibitory functions of tissue factor pathway inhibitor (Q40910806)

24 September 2017

title

The role of the C-terminal domain in the inhibitory functions of tissue factor pathway inhibitor (English)

1 reference

24 September 2017

Ettelaie C

1

1 reference

24 September 2017

Adam JM

2

1 reference

24 September 2017

James NJ

3

1 reference

24 September 2017

Oke AO

4

1 reference

24 September 2017

Harrison JA

5

1 reference

24 September 2017

Bunce TD

6

1 reference

24 September 2017

Bruckdorfer KR

7

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

24 September 2017

1 reference

24 September 2017

volume

463

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

341-344

1 reference

Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901663-4

The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901663-4

1-Hydroxy-7-azabenzotriazole. An efficient peptide coupling additive

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901663-4

Identification of a domain in apolipoprotein B-100 that inhibits the procoagulant activity of tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901663-4

Modification of tissue factor by peroxynitrite influences its procoagulant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901663-4

The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901663-4

Crystal structure of the extracellular region of human tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901663-4

Mutational mapping of functional residues in tissue factor: identification of factor VII recognition determinants in both structural modules of the predicted cytokine receptor homology domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901663-4

Comparison of the inhibitory effects of ApoB100 and tissue factor pathway inhibitor on tissue factor and the influence of lipoprotein oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901663-4

A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901663-4

Tissue factor pathway inhibitor activity associated with LDL is inactivated by cell- and copper-mediated oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901663-4

Development of a method to separate lipoprotein-bound and lipoprotein-depleted tissue factor pathway inhibitor. Measurement of free tissue factor pathway inhibitor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901663-4

The mechanism of inhibition of factor III (thromboplastin) activity by apolipoprotein B-100. Protein-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901663-4

Alterations in the structure of apolipoprotein B-100 determine the behaviour of LDL towards thromboplastin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901663-4

10.1016/S0014-5793(99)01663-4

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference